Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Patients & Carers meeting April 2017
January 11, 2019
Patients & Carers meeting March 2017
January 11, 2019
Patients & Carers meeting February 2017
January 11, 2019
Patients & Carers meeting January 2017
January 11, 2019
Patients & Carers meeting December 2016
January 11, 2019
Patients & Carers meeting November 2016
January 11, 2019
Patients & Carers meeting October 2016
January 11, 2019
Patients & Carers meeting September 2016
January 11, 2019
Patients & Carers meeting August 2016
January 11, 2019
Patients & Carers meeting July 2016
January 11, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video